Bruin Biometrics LLC

LOS ANGELES, July 9, 2024 /PRNewswire/ -- Bruin Biometrics, a leader in medical technology innovations, proudly announces its PIPPA (Pressure Injury Prevention Personal Assistant), will now integrate NPIAPs Standardized Pressure Injury Prevention Protocol (SPIPP) checklist 2.0. SPIPP's second version was introduced in 2023 (with the original version being based on the International Clinical Practice Guidelines 2019) and this milestone therefore highlights PIPPA's unique capability to revolutionise the prevention and management of hospital-acquired pressure injuries (HAPIs). Continue Reading PIPPA (Pressure Injury Prevention Personal Assistant) PIPPA (Pressure Injury Prevention Personal Assistant) "We are thrilled to introduce PIPPA, a game-changing platform that embodies our commitment to patient safety and innovative healthcare solutions," said Martin Burns, CEO of Bruin Biometrics. "Integration of the NPIAP's SPIPP checklist into PIPPA, along with the capabilities of our Provizio® SEM Scanner, will enable healthcare providers to adopt best practices effortlessly, ensuring better care and clinical outcomes." PIPPA is designed to integrate seamlessly with existing Electronic Medical Records, providing real-time data and analytics to healthcare providers. It automates the production of the SPIPP checklist, developed by NPIAP, ensuring high fidelity data collection and ease of use. This integration supports consistent and comprehensive application of the SPIPP checklist, helping to reduce the incidence of HAPIs and improve patient care. "The inclusion of the SPIPP checklist in Bruin Biometrics' PIPPA platform marks a significant advancement in the prevention of HAPIs," stated Dr Joyce Black, President of NPIAP. "This collaboration leverages our clinical guidelines with cutting-edge technology, providing healthcare providers with the tools they need to effectively reduce pressure injuries and improve patient outcomes." PIPPA's innovative features include automated audit trails, real-time data reporting, and comprehensive situational awareness for practitioners, managers, and administrators. Built on a secure cloud-based architecture, PIPPA ensures data protection and compliance with global safety standards. Additionally, PIPPA is fully integrated with Bruin Biometrics' Provizio SEM Scanner, a device used to identify increased risk of pressure injuries. This integration enables real-time monitoring and early intervention, significantly enhancing the effectiveness of pressure injury prevention strategies. For more information about PIPPA and its capabilities visit: For more information on Provizio SEM Scanner visit: . For more information about Bruin Biometrics contact Kate Hancock, EVP External Communications, at +447827315347 or [email protected] Media contact details: Joanna Dodd, Alicia Barkle Rochester PR Group: [email protected], [email protected] ABOUT Bruin Biometrics Bruin Biometrics LLC is a pioneer in modernizing healthcare with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians. Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles, USA. Copyright, trademarks and logos are the intellectual property of Bruin Biometrics LLC, this includes the following: Provizio® SEM Scanner and SEM Scanner® Bruin Biometrics LLCs copyright materials cannot be used or reproduced without Bruin Biometrics LLCs written consent. Pressure Injury Prevention Personal Assistant and PIPPA ("PIPPA") are marks of BBI Medical Solutions, LLC. PIPPA is distributed by Bruin Biometrics, LLC under license from BBI Medical Solutions, LLC. Logo - Logo - Photo -

ADDISON, Ill., March 13, 2024 /PRNewswire/ -- The Journal of Advanced Nursing has recently published a quality improvement project titled `Shedding new light for nurses: Enhancing PI prevention across skin tones with SEM assessment technology'. The project reveals implementation of SEM assessment technology enabled equitable pressure injury prevention for all population types and resulted in a 100% reduction in pressure injuries in a Critical Care Unit for 12 consecutive weeks. As mentioned within the publication "Reported hospital acquired pressure injury incidence rates are much higher in special care settings, including intensive/critical care, medical/surgical care and in individual population groups, including dark skin patients and veterans with spinal cord injuries." Led by Dr. Cynthia Osborne Chambers, the clinical team conducted an extensive analysis of data collected from a diverse cohort of critical care unit patients over a period of twelve weeks. Initial focus was on pressure injury prevention strategies using current standard of care. Then the Provizio® SEM Scanner was introduced for an additional twelve-week period to determine the impact of this objective, skin tone agnostic device. The findings highlight disparity in pressure injury incidence rate amongst dark tone skin patients compared to light skin tone patients. This disparity points to potential systemic issues that warrant an equitable and objective pressure injury prevention solution to be adopted as an adjunct to the current standard of care. The results of this project showed a 100% reduction in pressure injuries for all patients over the twelve-week period using the Provizio SEM Scanner as an adjunct to current standard of care for all patients, regardless of the patient's skin tone. Notably, 70% of patients in the cohort had dark tone skin highlighting the importance of this skin tone agnostic technology. To access this compelling study, please visit: Shedding new light for nurses: Enhancing pressure injury prevention across skin tones with sub-epidermal moisture assessment technology. For media inquiries or further information, please contact: Arjo Hailey Hotaki, MBA [email protected] Bruin Biometrics, LLC Kate Hancock [email protected] This information was brought to you by Cision SOURCE Arjo Inc.

LOS ANGELES, Feb. 2, 2024 /PRNewswire/ -- Bruin Biometrics LLC announces repeated formal recognition of the role of sub-epidermal moisture (SEM) in the identification of the increased risk of pressure injuries and of the Provizio SEM Scanner in the detection, and guided treatment of SEM for the prevention of broken skin pressure injuries. Martin Burns, CEO of Bruin Biometrics, brings good news: "An increasing number of national and expert guidelines now recognize SEM assessment for pressure injury prevention due to the latest data on the ongoing challenges of pressure injuries and the importance of their prevention. FDA, CMS, and device users now acknowledge the importance of that clinical foresight, which is acutely true for dark-skin-toned patients. Health economic modelling underscores its cost-effectiveness whilst freeing up healthcare practitioner time. 2023 was a year of groundbreaking clinical and health economic advancements with the Provizio SEM Scanner, the name of which was selected to suggest and highlight the 'foresight' this technology provides. The company and its collaborating practitioners and exclusive global distributor, Arjo, continue to modernise the landscape of pressure injury prevention in the US, with far-reaching positive effects for patients, globally. In the United States: The FDA has acknowledged that sub-epidermal moisture is the equivalent of persistent focal edema and localized edema: additionally, that sub-epidermal moisture is measured and monitored by the Provizio SEM Scanner, accepting an expanded labelling (K231830, September 2023). The US Centers for Medicare and Medicaid (CMS) has approved the ICD-10 PCS procedure code, XX2KXP9, for the SEM scanning procedure, effective April 1, 2024, It recognizes the utility of the technology in measuring and monitoring SEM which, when treated, significantly aids in preventing pressure injuries and deep tissue injuries. This new code will play a significant role in promoting standardization of the procedure, especially for present on admission testing which is a major quality risk area for providers with consequential Medicare penalties for missed diagnoses. These developments have broad implications for clinical practice. In the US, the 1% Medicare penalty for hospital-acquired pressure injuries again applies to clinical practice for the fiscal year from October 1, 2023, to September 30, 2024. Because of these Provizio SEM Scanner related milestones, healthcare providers and practitioners have coded procedures and a powerful tool for identifying and documenting pressure damage on admission, and Deep Tissue Injuries; and in particular for dark-skin toned patients. For years, healthcare practitioners and policymakers have been frustrated from increased pressure injury incidence and associated resource burdens and treatment costs. From Bruin Biometrics' point of the view the current status quo around pressure injuries is simply inadequate resulting in too much avoidable patient suffering. Burns concluded, "These approvals and authorizations are proverbial breaths of fresh air in a clinical area frustrated by detection, treatment and prevention methods not grounded in the contemporary etiology and pathophysiology. We have moved beyond the era of pressure injury risk-tools and visual and tactile skin assessments alone, and into an era where objective, microscopic measures guide practitioners' understanding of their patients' skin and tissue status." * A pressure injury can also be known as a pressure ulcer, pressure sore, decubitus ulcer and bed sore. For more information, please visit or contact Kate Hancock, EVP External Communications, at +447827315347 or [email protected]. Media contact details:    Joanna Dodd, Alicia Barkle Rochester PR Group : [email protected] / [email protected] 1 K231830, September 2023: "The Provizio SEM Scanner S measures the electrical capacitance of tissue ("Biocapacitance"), below the electrode when placed on the patient's skin. Biocapacitance is a biophysical measure of changes in sub-epidermal moisture ("SEM") a physiological process associated with pressure-induced tissue damage, The Provizio SEM Scanner is designed to measure changes in SEM which is equally known in literature as persistent focal edema, or localized edema. About Bruin Biometrics Bruin Biometrics, LLC, is a pioneer in modernizing health care with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians. Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles. SOURCE Bruin Biometrics, LLC